Cypress Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Buy |
+2,214
| New | +$245K | 0.07% | 79 |
|
|
2024
Q3 | – | Sell |
-13
| Closed | -$892 | – | 183 |
|
|
2024
Q2 | $892 | Buy |
+13
| New | +$892 | ﹤0.01% | 331 |
|
|
2022
Q1 | – | Sell |
-3,030
| Closed | -$220K | – | 215 |
|
|
2021
Q4 | $220K | Sell |
3,030
-180
| -6% | -$13.1K | 0.03% | 190 |
|
|
2021
Q3 | $224K | Buy |
3,210
+3,207
| +106,900% | +$224K | 0.03% | 171 |
|
|
2021
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 89 |
|
|
2021
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 113 |
|
|
2020
Q3 | – | Sell |
-22,595
| Closed | -$1.74M | – | 65 |
|
|
2020
Q2 | $1.74M | Buy |
+22,595
| New | +$1.74M | 0.77% | 16 |
|
|
2019
Q4 | $1.38M | Buy |
21,191
+92
| +0.4% | +$5.98K | 0.58% | 24 |
|
|
2019
Q3 | $1.34M | Sell |
21,099
-51
| -0.2% | -$3.23K | 0.61% | 21 |
|
|
2019
Q2 | $1.43M | Sell |
21,150
-984
| -4% | -$66.5K | 0.65% | 23 |
|
|
2019
Q1 | $1.44M | Buy |
22,134
+910
| +4% | +$59.2K | 0.6% | 26 |
|
|
2018
Q4 | $1.33M | Buy |
+21,224
| New | +$1.33M | 0.61% | 28 |
|